Toward 70% cervical cancer screening coverage: Technical challenges and opportunities to increase access to human papillomavirus (HPV) testing.

Journal: PLOS global public health

Volume: 3

Issue: 8

Year of Publication: 

Affiliated Institutions:  Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, United States of America. FIND, the Global Alliance for Diagnostics, Geneva, Switzerland. Department of Noncommunicable Diseases and Mental Health, Unit of Noncommunicable Diseases, Violence and Injury Prevention, Pan American Health Organization, Washington, DC, United States of America. Einstein-Rwanda Research and Capacity Building Program, Research for Development Rwanda and Rwanda Military Hospital, Kigali, Rwanda. Faculty of Medicine, Department of Obstetrics and Gynecology, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

Abstract summary 

The World Health Organization (WHO) has called for the elimination of cervical cancer as a public health problem. Cervical cancer screening through human papillomavirus (HPV) testing is a core component of the strategy for elimination, with a set target of screening 70% of women twice in their lifetimes. In this review, we discuss technical barriers and opportunities to increase HPV screening globally.

Authors & Co-authors:  Kundrod Kathryn A KA Jeronimo Jose J Vetter Beatrice B Maza Mauricio M Murenzi Gad G Phoolcharoen Natacha N Castle Philip E PE

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68: 394–424. doi: 10.3322/caac.21492
Authors :  7
Identifiers
Doi : e0001982
SSN : 2767-3375
Study Population
Women
Mesh Terms
Other Terms
Study Design
Study Approach
Country of Study
Publication Country
United States